noscript

News and Announcements

Xeophin answer the BIG question – Why are they undertaking an ICO?

  • Published June 19, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS

  • Xeophin visually explains why they’re undertaking an ICO
  • Xeophin’s Whitepaper is available now available
YouTube player

Xeophin have also released their whitepaper and is available for all investors interesting in their opportunity. To view their Whitepaper, please proceed to ‘request offer’.

 

About Xeophin

Xeophin Pty Ltd is a Biotech Company with a focus on imunomodulating technologies, and is committed to the research, development and commercialisation of new and novel medical treatments, in a number of high growth therapeutic areas such as inflammation.

Request Offer

Company Updates

View All
The Index Approach in Early-Stage Venture Capital: Reconsidered
Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Read more
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Read more
View All

Join over 45,000+ sophisticated investors

Join Now